CJC-1295 Changes Blood Protein Profiles: GH/IGF-1 Axis Activation Has Systemic Effects
CJC-1295 (long-acting GHRH analog) activation of the GH/IGF-1 axis produced measurable serum protein profile changes in healthy adults, revealing systemic metabolic effects beyond just hormone elevation.
Quick Facts
What This Study Found
CJC-1295 (long-acting GHRH analog) activation of the GH/IGF-1 axis produced measurable serum protein profile changes in healthy adults, revealing systemic metabolic effects beyond just hormone elevation.
Key Numbers
How They Did This
research study.
Why This Research Matters
Relevant for peptide research.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
Trust & Context
- Key Stat:
- Key finding CJC-1295 (long-acting GHRH analog) activation of the GH/IGF-1 axis produced measurable serum protein profile changes in healthy adults, revealing syst
- Evidence Grade:
- emerging evidence.
- Study Age:
- Published in 2009.
- Original Title:
- Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.
- Published In:
- Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 19(6), 471-7 (2009)
- Authors:
- Sackmann-Sala, Lucila, Ding, Juan, Frohman, Lawrence A(4), Kopchick, John J
- Database ID:
- RPEP-01542
Evidence Hierarchy
Frequently Asked Questions
What was studied?
CJC-1295 Changes Blood Protein Profiles: GH/IGF-1 Axis Activation Has Systemic Effects
What was found?
CJC-1295 (long-acting GHRH analog) activation of the GH/IGF-1 axis produced measurable serum protein profile changes in healthy adults, revealing systemic metabolic effects beyond just hormone elevation.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01542APA
Sackmann-Sala, Lucila; Ding, Juan; Frohman, Lawrence A; Kopchick, John J. (2009). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 19(6), 471-7. https://doi.org/10.1016/j.ghir.2009.03.001
MLA
Sackmann-Sala, Lucila, et al. "Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.." Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2009. https://doi.org/10.1016/j.ghir.2009.03.001
RethinkPeptides
RethinkPeptides Research Database. "Activation of the GH/IGF-1 axis by CJC-1295, a long-acting G..." RPEP-01542. Retrieved from https://rethinkpeptides.com/research/sackmann-sala-2009-activation-of-the-ghigf1
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.